Support.com & NeuroMetrix: Two trending stocks on Friday  

August 28, 2021 11:14 AM AEST | By Team Kalkine Media
 Support.com & NeuroMetrix: Two trending stocks on Friday  
Image source: whiteMocca, Shutterstock

Highlights

  • Support.com (NASDAQ:SPRT) stock was up 43.15% at 3:49 pm ET.

  • NeuroMetrix, Inc. (NASDAQ:NURO) was up 60.88% at 3:50 pm ET.

  • com gave a 1096.82% return YTD, while NeuroMetrix returned 422.47% YTD.        


Stocks of Support.com (NASDAQ:SPRT) and NeuroMetrix, Inc. (NASDAQ:NURO) were up 43% and 60%, respectively, on Friday as they drew investors’ attention following a social media buzz.

Support.com stock was priced at US$28.20, up 43.15%, at 3:49 pm ET, while NeuroMetrix Stock traded at US$16.04, up 60.88%, at 3:50 pm ET.


Here we look at the recent developments of the two companies.
 

Support.com, Inc. It is a technology company that provides cloud-based software and services. The Wilmington, Delaware, headquartered company has a market cap of US$851 million. 

The stock witnessed a massive trading volume, registering 105,897,900 stocks in Friday’s session. The stock gained nearly 70% in two days. The stock rallied after it started trending on social media forums. 

Also Read: Styling it right: Six fashion stocks that are hard to miss

The company’s revenue was US$8.51 million in Q2 ended June 30, 2021, compared to US$11.0 million in the corresponding quarter of the previous year.

The net loss was US$799 thousand or US$0.03 per share diluted, against a net income of US$617 thousand or US$0.03 per share diluted. The liquidity reserves were US$32.30 million at the end of the June quarter this year. 

The company went public in 2000. Its YTD return is 1096.82%.

Also Read: Are these six blue-chip stocks primed to lead the banking recovery? 

Source – pixabay

Also Read: Are you an NFT fan? Check out these seven hot NFTs in the market

NeuroMetrix, Inc.  

It is a healthcare company and produces medicine for chronic health conditions. The Massachusetts-based company has a market capitalization of US$92.9 million. 

The stock saw a significant trading volume on Friday, almost ten times its average. It was 2,041,231 on Thursday. There was no apparent reason behind Friday’s stock rally, except that it finds mention on some social media forums.

On July 20, 2020, NURO had announced receiving FDA breakthrough designation for its Quell device. The stock has been declining since then until Friday’s 65% jump.

Also Read: Five high-flying communication stocks to watch this fall

For the quarter ended June 30, 2021, the revenue was US$2.2 million compared to US$1.4 million in the June quarter of 2020. It booked a net loss of US$531 thousand or US$0.13 per share diluted, compared to a net loss of US$852 thousand for the same period the prior year. Its liquidity reserves were US$8.36 million as of June 3, 2021.

The company launched its IPO in 2004. The stock gave a 422.47% return YTD.

Also Read: Penny wise or pound foolish? Here are 5 penny stocks to explore

Bottomline


The stocks rallied on Friday after it caught the attention of social media users, underscoring the power they wield.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.